Mucosal healing and fibrosis after acute or chronic inflammation in wild type FVB-N mice and C57BL6 procollagen α1(I)-promoter-GFP reporter mice

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ding, Shengli ^a   Walton, Kristen L W ^b   Blue, Randall Eric ^a   MacNaughton, Kirk ^a   Magness, Scott T ^c   Lund, Pauline Kay ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MISSOURI WESTERN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; DEXTRAN SULFATE; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PROCOLLAGEN; PROCOLLAGEN ALPHA1(I); TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; INTESTINAL FIBROSIS; INTESTINE MUCOSA; MALE; MORTALITY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEX DIFFERENCE; WILD TYPE; WOUND HEALING;

ACUTE DISEASE; ANIMALS; ANTIGENS; CHRONIC DISEASE; COLLAGEN TYPE I; COLON; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; INFLAMMATION; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOFIBROBLASTS; PROMOTER REGIONS, GENETIC; SURVIVAL ANALYSIS; TRINITROBENZENESULFONIC ACID; VIMENTIN; WEIGHT LOSS; WOUND HEALING;

MUS;

EID: 84864557487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042568     Document Type: Article

References (30)

1. Fiocchi C, Lund PK, ((2011)) Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol 300:: G677--683.
2. Luna J, Masamunt MC, Lawrance IC, Sans M, ((2011)) Mesenchymal cell proliferation and programmed cell death: key players in fibrogenesis and new targets for therapeutic intervention. Am J Physiol Gastrointest Liver Physiol 300:: G703--708.
3. Rieder F, Fiocchi C, ((2009)) Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 6:: 228--235.
4. Pucilowska JB, McNaughton KK, Mohapatra NK, Hoyt EC, Zimmermann EM, et al. ((2000)) IGF-I and procollagen alpha1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol 279:: G1307--1322.
5. Szabo H, Fiorino G, Spinelli A, Rovida S, Repici A, et al. ((2010)) Review article: anti-fibrotic agents for the treatment of Crohn's disease- lessons learnt from other diseases. Aliment Pharmacol Ther 31:: 189--201.
6. Cooper HS, Murthy SN, Shah RS, Sedergran DJ, ((1993)) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:: 238--249.
7. Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, et al. ((1998)) Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274:: G544--551.
8. Mahler M, Bristol IJ, Sundberg JP, Churchill GA, Birkenmeier EH, et al. ((1999)) Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics 55:: 147--156.
9. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, et al. ((1990)) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:: 694--702.
10. Williams KL, Fuller CR, Dieleman LA, DaCosta CM, Haldeman KM, et al. ((2001)) Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120:: 925--937.
11. Melgar S, Karlsson A, Michaelsson E, ((2005)) Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288:: G1328--1338.
12. Suzuki K, Sun X, Nagata M, Kawase T, Yamaguchi H, et al. ((2011)) Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium. Pathol Int 61:: 228--238.
13. Krempen K, Grotkopp D, Hall K, Bache A, Gillan A, et al. ((1999)) Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice. Gene Expr 8:: 151--163.
14. Magness ST, Bataller R, Yang L, Brenner DA, ((2004)) A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 40:: 1151--1159.
15. Wirtz S, Neufert C, Weigmann B, Neurath MF, ((2007)) Chemically induced mouse models of intestinal inflammation. Nat Protoc 2:: 541--546.
16. Sasaoka T, Ito M, Yamashita J, Nakajima K, Tanaka I, et al. ((2011)) Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. Am J Physiol Gastrointest Liver Physiol 300:: G568--576.
17. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, et al. ((1989)) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:: 795--803.
18. te Velde AA, Verstege MI, Hommes DW, ((2006)) Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 12:: 995--999.
19. Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, et al. ((2001)) Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome. Gastroenterology 120:: 834--840.
20. Saruta M, Michelsen KS, Thomas LS, Yu QT, Landers CJ, et al. ((2009)) TLR8-mediated activation of human monocytes inhibits TL1A expression. Eur J Immunol 39:: 2195--2202.
21. Dave M, Loftus EV Jr, ((2012)) Mucosal healing in inflammatory bowel disease-a true paradigm of success? Gastroenterol Hepatol (N Y) 8:: 29--38.
22. Lawrance IC, Wu F, Leite AZ, Willis J, West GA, et al. ((2003)) A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology. 125:: 1750--1761.
23. Koon HW, Shih D, Karagiannides I, Zhao D, Fazelbhoy Z, et al. ((2010)) Substance P modulates colitis-associated fibrosis. Am J Pathol 177:: 2300--2309.
24. Klopcic B, Appelbee A, Raye W, Lloyd F, Jooste JC, et al. ((2008)) Indomethacin and retinoic acid modify mouse intestinal inflammation and fibrosis: a role for SPARC. Dig Dis Sci 53:: 1553--1563.
25. Mahavadi S, Flynn RS, Grider JR, Qiao LY, Murthy KS, et al. ((2011)) Amelioration of excess collagen IalphaI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice. Inflamm Bowel Dis 17:: 711--719.
26. Strober W, Kitani A, Fichtner-Feigl S, Fuss IJ, ((2009)) The signaling function of the IL-13Ralpha2 receptor in the development of gastrointestinal fibrosis and cancer surveillance. Curr Mol Med 9:: 740--750.
27. Grassl GA, Valdez Y, Bergstrom KS, Vallance BA, Finlay BB, ((2008)) Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology 134:: 768--780.
28. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, et al. ((2006)) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45:: 429--438.
29. Yata Y, Scanga A, Gillan A, Yang L, Reif S, et al. ((2003)) DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 37:: 267--276.
30. Pucilowska JB, Williams KL, Lund PK, ((2000)) Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol 279:: G653--659.